Iambic Therapeutics, Inc.
Amendment
CIK: 0001997038·Biotechnology·DELAWARE·Filed: Jun 6, 2024
Total Offering
$49,999,998
Amount Sold
$38,383,040
Investors
11
First Sale
Apr 15, 2024
Offering Details
- Type
- Equity
- Exemptions
- Rule 506(b)
- Entity Type
- Corporation
- Year Incorporated
- 2019
- Non-Accredited Investors
- No
Related Persons
| Name | Role |
|---|---|
| R. Jacob Vogelstein | Related Person |
| Tabbert Teng | Related Person |
| Thomas Miller | Related Person |
| Jishnu Bhattacharjee | Related Person |
| Neil Josephson | Related Person |
| Fred Manby | Related Person |
| Evan Rachlin | Related Person |
| William Rastetter | Related Person |
| Kurt von Emster | Related Person |
Company
SEC Filing
0001997038-24-000003
View on SEC EDGARWant deeper insights?
Sign up for free to search all filings, track companies, and set up alerts.
Sign Up Free